4 min read
Peptides: The Less-is-More Strategy for Success
By Jennifer Somera on May 6, 2021 6:56:44 PM
A strategic approach to peptide design yields success
When deciding which antigens to use for an antibody discovery project, there are many available options. Peptides, which have been around for at least 60 years, are one way in. Other — and, in many cases, newer — available paths include recombinant proteins, engineered cells and DNA coding for the protein.
Topics: News Insights SARS-CoV-2 Antibody Discovery Peptides
Filter by Keyword
- Insights (34)
- Events (16)
- COVID-19 (15)
- SARS-CoV-2 (14)
- News (11)
- Molecular Modeling (9)
- Transgenic Animals (6)
- Antibody Discovery (4)
- Therapeutic Targets (3)
- 25th Anniversary (2)
- Omicron (2)
- Therapeutic Monoclonal Antibodies (2)
- Antibody Generation (1)
- Antibody-Drug Conjugate (ADC) (1)
- Antigen (1)
- CAR-T (1)
- Cell Fusion (1)
- Cell therapy (1)
- Functional Assays (1)
- Harbour (1)
- Hybridoma (1)
- IgG purification (1)
- Immunoassays (1)
- Immunogens (1)
- Lambda Light Chain (1)
- Lambda Mouse (1)
- MAbExpress (1)
- Monoclonal (1)
- OmniRat (1)
- Peptides (1)
- Syngeneic (1)
- Target Analysis (1)
- Transgenic H2L2 Mice (1)
- Women In Bio (1)
- igG (1)
- mRNA (1)